Bank of New York Mellon »

Crescent Biopharma shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-06-30 $824k 46k 18.00

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Logos Global Management
Fcpm Iii Services B.v.
Balyasny Asset Management
Vestal Point Capital
Opaleye Management
BlackRock
Tang Capital Management
Vanguard Capital Management
Millennium Management
Geode Capital Management
Jennison Associates

View all funds holding Crescent Biopharma